Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 3,631,494 7.400% |
894,441 (+32.68%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,458,958 6.500% |
-293,237 (-10.65%) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,072,587 5.000% |
91,263 (+3.06%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 178,177 0.400% |
-1,976,957 (-91.73%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,078,092 7.100% |
-63,405 (-2.96%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Citadel Advisors LLC | 2,034,260 3.400% |
-851,832 (-29.52%) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Citadel Advisors LLC | 1,649,664 7.400% |
15,515 (+0.95%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Northern Star Investment Corp. II NSTB |
Citadel Advisors LLC | 806 0.000% |
-50,128 (-98.42%) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Citadel Advisors LLC | 2,265 0.000% |
2,265 (New Position) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Turtle Beach Corporation TBCH |
Citadel Advisors LLC | 223,036 1.300% |
-683,735 (-75.40%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Appian Corporation APPN |
Citadel Advisors LLC | 1,372,895 3.300% |
-584,302 (-29.85%) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Forbion European Acquisition Corp. FRBN |
Citadel Advisors LLC | 0 0.000% |
-1,075,058 (Position Closed) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Khosla Ventures Acquisition Co. KVSA |
Citadel Advisors LLC | 0 0.000% |
-2,705,290 (Position Closed) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO |
Citadel Advisors LLC | 0 0.000% |
-2,241,549 (Position Closed) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Apollo Strategic Growth Capital II APGB |
Citadel Advisors LLC | 0 0.000% |
-4,078,643 (Position Closed) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Artemis Strategic Investment Corporation ARTE |
Citadel Advisors LLC | 0 0.000% |
-1,621,525 (Position Closed) |
Filing History |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 0 0.000% |
-1,863,411 (Position Closed) |
Filing History |
| 2024-01-22 4:04 pm Purchase |
2024-01-12 | 13G | NETSTREIT Corp. NTST |
Citadel Advisors LLC | 4,108,199 5.200% |
4,108,199 (New Position) |
Filing History |
| 2024-01-02 4:14 pm Purchase |
2023-12-20 | 13G | COMPASS Pathways plc CMPS |
Citadel Advisors LLC | 3,195,517 5.000% |
3,195,517 (New Position) |
Filing History |
| 2023-12-26 4:47 pm Purchase |
2023-12-15 | 13G | Allurion Technologies Inc. ALUR |
Citadel Advisors LLC | 102,285 5.100% |
102,285 (New Position) |
Filing History |